GLP-1 operates through multiple mechanisms, including reducing hunger, increasing a sense of fullness after meals, boosting energy expenditure, and improving insulin sensitivity
Choosing between them depends on factors such as treatment goals, side effect profile, availability, and individual response, which is why professional guidance is essential
Copays can range from $10 to $50 per month
Participants in this phase 3 trial saw remarkable outcomes at 80 weeks: a weight loss averaging 28.3% on the 12 mg dose
With genetic guidance, PlexusDx can optimize your tirzepatide dose and potentially recommend complementary compounds if needed
Acknowledgements The authors would like to thank Henrik Kim Nielsen, Jens Heisterberg, and Karen Hauda (Novo Nordisk A/S, Denmark), and Gina MacNeil (Novo Nordisk Inc, United States) for review of, and input to, the manuscript, as well as Tina stergaard, Sisse Lakner Schmidt, and Michala Cronberg (Novo Nordisk A/S, Denmark) for help with physical stability analyses